Abiopharma

Spero Therapeutics Announces Third Quarter 2025 Operating Results and Provides a Business Update

Anebulo Pharmaceuticals Reports First Quarter Fiscal Year 2026 Financial Results and Recent Updates

Trevi Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Updates

Vaxart Provides Business Update and Reports Third Quarter 2025 Financial Results

Precigen Reports Third Quarter 2025 Financial Results and Business Updates

Evofem Reports Financial Results for Third Quarter of 2025, Provides Business Update

Reviva Reports Third Quarter 2025 Financial Results and Recent Business Highlights

SeaStar Medical Reports Third Quarter 2025 Financial Results and Provides Business Updates

Biohaven Announces Closing of Upsized Public Offering and Full Exercise of the Underwriters Option to Purchase Additional Shares, Generating Gross Proceeds of Approximately $200M

Autolus Therapeutics to Participate in the Jefferies Global Healthcare Conference in London